BackKailera Therapeutics Overview

Kailera Therapeutics Current Cash

Kailera Therapeutics's current cash is $130M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$130.30M

Peer trimmed avg / median

Loading

Kailera Therapeutics Current Cash History

Loading

Kailera Therapeutics vs. peers: Current Cash Comparison

Loading

Kailera Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Kailera Therapeutics (KLRA) FAQ

Kailera Therapeutics (KLRA) currently reports a current cash of $130M as of June 2026. Use the charts on this page to explore Kailera Therapeutics's current cash history and peer comparisons.

Kailera Therapeutics reported $130M in current cash as of June 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $130M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Kailera Therapeutics, and consider following KLRA for alerts when major investors trade the stock.

Kailera Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $130M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing KLRA with unrelated industries.